MRNA Filing
10-QFiling Date: Jul 31, 2026

Moderna, Inc. (MRNA) · Quarterly Report (10-Q) SEC Filing

mrna-20260630

descriptionView SEC Filing
ACC: 0001682852-26-000150open_in_new
Key Financial MetricsFY2026 · 2026-06-30
Revenue$145.0M
Net Income-$782.0M
Total Assets$10.96B
Stockholders' Equity$6.76B
Operating Cash Flow-$1.16B

keid AI analysis is for reference only and does not constitute investment advice.